Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Nicholas Richardson

8PUBLICATIONS

57CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesMolecular targetsHaematological tumoursMedical bacteriology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Mar 12, 2026

A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano study.

Richard Scott Swain, Andrew Klink, Parisa Asgarisabet

|Jul 15, 2025

FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma.

Kristen Britton, Upendra Mahat, Nicholas C Richardson

|Oct 15, 2024

FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas.

Maryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu

|Dec 12, 2023

Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development.

Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco

|Apr 03, 2023

The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990-2018.

Nadia Howlader, Elad Sharon, Manami Bhattacharya

|Mar 09, 2023

Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective.

Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon

Pageof 2

Frequent Collaborators

4 joint publications

Marc R Theoret

4 joint publications

Nicole J Gormley

3 joint publications

Richard Pazdur

2 joint publications

Maryam Sarraf Yazdy

2 joint publications

Yvette L Kasamon

2 joint publications

Bindu Kanapuru

2 joint publications

Lola A Fashoyin-Aje

2 joint publications

R Angelo de Claro

1 joint publications

Andrea C Baines

1 joint publications

Margret Merino

Frequent Collaborators

4 joint publications

Marc R Theoret

4 joint publications

Nicole J Gormley

3 joint publications

Richard Pazdur

2 joint publications

Maryam Sarraf Yazdy

Top Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on : Apr 18, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos

Top Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on : Apr 18, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos